EVNIA
Desconocido
2D-BioPAD: Supple Graphene Bio Platform for point of care early detection and monitoring of Alzheimer s Disease
EVNIA APS
participó en un
HORIZON EUROPE:
HORIZON-CL4-2022-DIGITAL-EMERGING-02
2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Al...
2023-06-29 - 2027-09-30 | Financiado
2023-06-29 - 2027-09-30 | Financiado
* No se disponen de datos de la empresa actual.